Skip to content

Efficacy and Safety Aspects of Biodegradable Fixation Systems: a Randomized Clinical Trial.

Efficacy and Safety Aspects of Biodegradable Fixation Systems: a Randomized Clinical Trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27878
Enrollment
230
Registered
2006-09-19
Start date
2006-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Fixing bone segments in the maxillofacial skeleton with titanium or biodegradable fixation devices.

Sponsors

Stryker Nederland
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. patients scheduled for a solitair Le Fort I fractures, and/or; 2. patients scheduled for a solitair of multiple mandibula fracture(s), and/or; 3. patients scheduled for a solitair zygoma fracture, and/or; 4. patients scheduled for a Le Fort I osteotomy, and/or; 5. patients scheduled for a BSSO, and/or; 6. patients who signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. severe chronically ill patients (i.e.. diabetis mellites); 2. patients by whom compromised bone healing has been established (i.e. osteoporosis); 3. patients who are submerged through an infection; 4. patients who are pregnant; 5. patients who could not participate in a long follow-up (reasons); 6. patients who already have received maxillary surgery in the past (i.e,. schisis); 7. patients who are diagnosed with a psychiatric disorder (diagnosed by a psychiatrist); 8. patients who will not agree with an at random assignment to one of the treatment groups or one of the methods of treatment used in the study; 9. patients younger than 18 year regarding patients treated for fractures and patients younger that 14 regarding patients treated for osteotomies.

Design outcomes

Primary

MeasureTime frame
Bone healing is the primary outcome measure. The definition of bone healing is: healing of the bone segments after 8 weeks without clinical and radiological signs of disturbed bone healing. Bone healing related complications are not allowed during this period.

Secondary

MeasureTime frame
1. inflammatory reaction present (redness, swelling, sensitivity, warmth, function impairment, fistula or pus drainage), assessment visual and manually; 2. seriousness inflammatory reaction (mild, serious), assessment visual and manually; 3. palpability, assessment manually; 4. dehiscence, assessment visual; 5. occlusion, assessment visual. bone formation (screw holes, fracture crevice); 6. pain, evaluated by a Visual Analogue Scale (VAS); 7. cold/warm sensitivity; 8. mandibular function, evaluated by a Mandibular Function Impairment Questionnaire (MFIQ). 9. direct costs within the de health care; 10. direct costs outside the health care; 11. indirect costs outside the health care. 12. antibiotic use; 13. analgesic use; 14. re-operation required; 15. reasons re-operations (plate/screw exposition, plat/screw fracture, loosening of plates and screws, inadequate bone healing, inadequate reduction, infection or other reasons).

Contacts

Public ContactG.M. Raghoebar

University Medical Center Groningen (UMCG) Department of Oral Sugery P.O. Box 30001

g.m.raghoebar@kchir.umcg.nl+31(0)50 3613186

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)